1. Home
  2. KROS vs LVRO Comparison

KROS vs LVRO Comparison

Compare KROS & LVRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KROS
  • LVRO
  • Stock Information
  • Founded
  • KROS 2015
  • LVRO 2017
  • Country
  • KROS United States
  • LVRO Brazil
  • Employees
  • KROS N/A
  • LVRO N/A
  • Industry
  • KROS Biotechnology: Pharmaceutical Preparations
  • LVRO Blank Checks
  • Sector
  • KROS Health Care
  • LVRO Finance
  • Exchange
  • KROS Nasdaq
  • LVRO Nasdaq
  • Market Cap
  • KROS 460.6M
  • LVRO 387.1M
  • IPO Year
  • KROS 2020
  • LVRO N/A
  • Fundamental
  • Price
  • KROS $11.00
  • LVRO $4.46
  • Analyst Decision
  • KROS Buy
  • LVRO Strong Buy
  • Analyst Count
  • KROS 11
  • LVRO 3
  • Target Price
  • KROS $45.33
  • LVRO $5.83
  • AVG Volume (30 Days)
  • KROS 2.1M
  • LVRO 8.8K
  • Earning Date
  • KROS 02-26-2025
  • LVRO 02-03-2025
  • Dividend Yield
  • KROS N/A
  • LVRO N/A
  • EPS Growth
  • KROS N/A
  • LVRO N/A
  • EPS
  • KROS N/A
  • LVRO N/A
  • Revenue
  • KROS $651,000.00
  • LVRO $1,667,345,189.00
  • Revenue This Year
  • KROS $303.27
  • LVRO N/A
  • Revenue Next Year
  • KROS N/A
  • LVRO $12.53
  • P/E Ratio
  • KROS N/A
  • LVRO N/A
  • Revenue Growth
  • KROS 8037.50
  • LVRO N/A
  • 52 Week Low
  • KROS $9.78
  • LVRO $3.06
  • 52 Week High
  • KROS $73.00
  • LVRO $8.25
  • Technical
  • Relative Strength Index (RSI)
  • KROS 24.79
  • LVRO 53.50
  • Support Level
  • KROS $11.04
  • LVRO $4.06
  • Resistance Level
  • KROS $11.99
  • LVRO $5.00
  • Average True Range (ATR)
  • KROS 0.60
  • LVRO 0.41
  • MACD
  • KROS 1.20
  • LVRO 0.13
  • Stochastic Oscillator
  • KROS 43.99
  • LVRO 72.16

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

About LVRO Lavoro Limited

Lavoro Ltd operates in the agricultural inputs retail market, with operations spread across Brazil and Colombia, and an emergent agricultural input trading company in Uruguay. The reportable segments of the company include the Brazil Ag Retail, which comprises companies dedicated to the distribution of agricultural inputs such as crop protection, seeds, fertilizers and specialty products, in Brazil; Latam Ag Retail, which includes companies dedicated to the distribution of agricultural inputs outside Brazil (predominantly in Colombia); and the Crop Care. A substantial part of the company's overall revenue is generated from its Brazil Ag Retail segment.

Share on Social Networks: